Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Csaba Matyas

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Hepatology (Baltimore, Md.)|August 31, 2019
Interplay of Liver-Heart Inflammatory Axis and Cannabinoid 2 Receptor Signaling in an Experimental Model of Hepatic CardiomyopathyCsaba Matyas, Katalin Erdelyi, Eszter Trojnar, et al.
Hepatology (Baltimore, Md.)|April 10, 2018
Disruption of Renal Arginine Metabolism Promotes Kidney Injury in Hepatorenal Syndrome in MiceZoltan V Varga, Katalin Erdelyi, Janos Paloczi, et al.
Brain, Behavior, and Immunity|April 24, 2024
PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injuryJosephin Wagner, Lauren M Park, Partha Mukhopadhyay, et al.
Scientific Reports|November 22, 2019
PCSK9 inhibition as a novel therapeutic target for alcoholic liver diseaseJi Soo Lee, Partha Mukhopadhyay, Csaba Matyas, et al.
JACC. Basic to Translational Science|December 14, 2023
PCSK9, A Promising Novel Target for Age-Related Cardiovascular DysfunctionCsaba Matyas, Eszter Trojnar, Suxian Zhao, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Hepatology (Baltimore, Md.)|August 31, 2019
Interplay of Liver-Heart Inflammatory Axis and Cannabinoid 2 Receptor Signaling in an Experimental Model of Hepatic CardiomyopathyCsaba Matyas, Katalin Erdelyi, Eszter Trojnar, et al.
Hepatology (Baltimore, Md.)|April 10, 2018
Disruption of Renal Arginine Metabolism Promotes Kidney Injury in Hepatorenal Syndrome in MiceZoltan V Varga, Katalin Erdelyi, Janos Paloczi, et al.
Brain, Behavior, and Immunity|April 24, 2024
PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injuryJosephin Wagner, Lauren M Park, Partha Mukhopadhyay, et al.
Scientific Reports|November 22, 2019
PCSK9 inhibition as a novel therapeutic target for alcoholic liver diseaseJi Soo Lee, Partha Mukhopadhyay, Csaba Matyas, et al.
JACC. Basic to Translational Science|December 14, 2023
PCSK9, A Promising Novel Target for Age-Related Cardiovascular DysfunctionCsaba Matyas, Eszter Trojnar, Suxian Zhao, et al.
Pageof 2